Research never stops

Top Story

Evotec to attend three upcoming investor conferences

Hamburg, Germany, 30 January 2017:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at the Jefferies' 2017 Celgene Collaborators Summit in New York City, USA, and will be attending the Bankhaus Lampe German Equity Forum, London, UK, and the 11th ODDO German Conference, Frankfurt, Germany.

Bankhaus Lampe German Equity Forum, London, UK
Date: Thursday, 02 February 2017
Venue: London, UK
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

11th ODDO German Conference, Frankfurt, Germany
Date: Thursday, 16 February 2017
Venue: Frankfurt, Germany
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

Jefferies' 2017 Celgene Collaborators Summit, New York City, USA
Date: Tuesday, 21 February 2017
Venue: New York City, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

 

FORWARD LOOKING STATEMENTS
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.